T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency–a 22-month follow-up

A Hurme, P Jalkanen, M Marttila-Vaara… - Frontiers in …, 2023 - frontiersin.org
Primary antibody deficiencies, such as common variable immunodeficiency (CVID), are
heterogenous disease entities consisting of primary hypogammaglobulinemia and impaired …

[HTML][HTML] T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVID

R Cezar, L Kundura, S André, JY Lefrant… - Frontiers in …, 2024 - frontiersin.org
Background As about 10% of patients with COVID-19 present sequelae, it is important to
better understand the physiopathology of so-called long COVID. Method To this aim, we …

Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency

L Kundura, R Cezar, E Ballongue, S André… - The Journal of …, 2024 - journals.aai.org
Study design All patients were diagnosed as being SARS-CoV-2-infected by RT-PCR. Their
blood was drawn on the first day of hospitalization at an intensive care unit (ICU) or a non …

Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality

MC Albert, I Uranga-Murillo, M Arias… - Cell Death & …, 2024 - nature.com
The dysregulated immune response and inflammation resulting in severe COVID-19 are still
incompletely understood. Having recently determined that aberrant death-ligand-induced …

Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti–SARS-CoV-2 antibodies in the absence of CXCL13

M Azarias Da Silva, P Nioche, C Soudaramourty… - Science …, 2023 - science.org
Since the initial spread of severe acute respiratory syndrome coronavirus 2 infection, several
viral variants have emerged and represent a major challenge for immune control …

The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long …

M Noviello, R De Lorenzo, R Chimienti… - Frontiers in …, 2024 - frontiersin.org
Introduction SARS-CoV-2 pandemic still poses a significant burden on global health and
economy, especially for symptoms persisting beyond the acute disease. COVID-19 …

Impacts des traitements pour les maladies auto-immunes sur la capacité à générer des anticorps neutralisants à la suite de la vaccination contre le SRAS-CoV-2

S Gentil - 2023 - corpus.ulaval.ca
Résumé Les inquiétudes liées aux variants du SRAS-CoV-2 et l'efficacité des vaccins
actuels ont augmenté dû aux mutations accumulées dans la glycoprotéine Spike, la cible …